Oxford capital eis fund
    • About Us

      Learn more about us


      See our current oppurtunities


      Meet our team

      EIS investment faqs


      See our frequently asked questions


      See our latest news articles

      Contact Us

      Get in touch with us

Oxford BioTherapeutics and Kite establish cell therapy research collaboration

Positive news for our portfolio company, Oxford BioTherapeutics, it has announced a research collaboration with Kite, the global leader in cell therapy to evaluate five novel targets for a number of hematologic and solid tumor indications.

Share Post: